Molecular Insight Pharmaceuticals, Inc. 4
4 · Molecular Insight Pharmaceuticals, Inc. · Filed Dec 4, 2007
Insider Transaction Report
Form 4
LaFrance Norman D.
Sr. VP Clinical Dev and CMO
Transactions
- Purchase
Common Stock
2007-11-30$8.75/sh+100$875→ 2,100 total - Purchase
Common Stock
2007-11-30$8.78/sh+1,900$16,682→ 4,000 total